Relationship between chemotherapy-induced peripheral neuropathy and physical activity in cancer survivors: A prospective longitudinal study

被引:1
|
作者
Kyota, Ayumi [1 ]
Kinjo, Taeko [2 ]
Kanda, Kiyoko [3 ]
Hosokawa, Mai [4 ]
Higuchi, Daisuke [5 ]
机构
[1] Gunma Univ, Grad Sch Hlth Sci, Maebashi, Gunma, Japan
[2] Gunma Univ Hosp, Div Nursing, Maebashi, Gunma, Japan
[3] Niigata Coll Nursing, Niigata, Japan
[4] Iwate Prefectural Univ, Fac Nursing, Grad Sch Nursing, Takizawa, Iwate, Japan
[5] Takasaki Univ Hlth & Welf, Dept Phys Therapy, Takasaki, Gunma, Japan
关键词
Peripheral neuropathy; Cancer; Exercise therapy; Pedometer; Numbness; FUNCTIONAL-ASSESSMENT; VALIDATION; SCALE;
D O I
10.1016/j.apjon.2024.100507
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Objective: The purpose of this research is to evaluate the relationship between the degree of peripheral neuropathy associated with treatment and physical activity through the use of objective indicators such as wristband activity tracker and subjective evaluations obtained through interviews. Methods: This study included 11 patients with gynecological cancer, gastrointestinal cancer, and malignant lymphoma. Participants were requested to wear a wristband activity meter at two time points: early and midtreatment. Activity-meter step counts were compared with factors such as energy expenditure and Functional Assessment of Cancer Therapy-General during early and mid-treatment. Interviews were analyzed qualitatively and inductively. Results: There was no difference in the number of steps taken by participants in the early and mid-treatment periods (P = 0.050), but they took more steps in the mid-treatment period than in the early period. Participants expended more energy during mid-treatment than early treatment, but these differences were not significant. We noted a correlation between the number of steps and energy expenditure in the mid-treatment period (r = 0.883). Comparisons between measures showed significant differences in "Impact" between early and midtreatment on Distress and Impact Thermometer (P = 0.034). The impact of numbness on activity was assigned to three categories: loss of routine caused by numbness, coping with the numbness-related inconvenience using various resources, and acceptance of life with numbness with the support of others and self-strength. Conclusions: The participants devised strategies to maintain activities despite experiencing chemotherapy-induced peripheral neurotoxicity. The use of activity meters may enhance patient motivation, which in our opinion, is beneficial for self-care education.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Association Between Physical Activity Levels and Chemotherapy-Induced Peripheral Neuropathy Severity in Cancer Survivors
    Wilcoxon, Anna
    Kober, Kord M.
    Viele, Carol
    Topp, Kimberly
    Smoot, Betty
    Abrams, Gary
    Chesney, Margaret
    Paul, Steven M.
    Conley, Yvette P.
    Levine, Jon D.
    Miaskowski, Christine
    ONCOLOGY NURSING FORUM, 2020, 47 (06) : 703 - 719
  • [2] Chemotherapy-induced peripheral neuropathy in the detroit research on cancer survivors (ROCS) cohort
    Sreeram, Kalyan
    Seaton, Randell
    Greenwald, Mark K.
    Kamgar, Mandana
    Assad, Hadeel
    Baird, Tara
    Schwartz, Ann G.
    Ruterbusch, Julie
    Simon, Michael S.
    CANCER CAUSES & CONTROL, 2023, 34 (05) : 459 - 468
  • [3] Chemotherapy-induced peripheral neuropathy in the detroit research on cancer survivors (ROCS) cohort
    Kalyan Sreeram
    Randell Seaton
    Mark K. Greenwald
    Mandana Kamgar
    Hadeel Assad
    Tara Baird
    Ann G. Schwartz
    Julie Ruterbusch
    Michael S. Simon
    Cancer Causes & Control, 2023, 34 : 459 - 468
  • [4] Chemotherapy-Induced Neuropathy in Cancer Survivors
    Miaskowski, Christine
    Mastick, Judy
    Paul, Steven M.
    Topp, Kimberly
    Smoot, Betty
    Abrams, Gary
    Chen, Lee-May
    Kober, Kord M.
    Conley, Yvette P.
    Chesney, Margaret
    Bolla, Kay
    Mausisa, Grace
    Mazor, Melissa
    Wong, Melisa
    Schumacher, Mark
    Levine, Jon D.
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2017, 54 (02) : 204 - +
  • [5] Development and validation of the comprehensive assessment scale for chemotherapy-induced peripheral neuropathy in survivors of cancer
    Kanda, K.
    Fujimoto, K.
    Mochizuki, R.
    Ishida, K.
    Lee, B.
    BMC CANCER, 2019, 19 (01)
  • [6] Patterns of Patient-Reported Chemotherapy-Induced Peripheral Neuropathy in Colorectal Cancer Survivors
    Teng, Christina
    Venkatesha
    Blinman, Prunella L.
    Vardy, Janette L.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (12): : 1308 - 1315
  • [7] Associations Between Perceived Stress and Chemotherapy-Induced Peripheral Neuropathy and Otoxicity in Adult Cancer Survivors
    Miaskowski, Christine
    Paul, Steven M.
    Mastick, Judy
    Abrams, Gary
    Topp, Kimberly
    Smoot, Betty
    Kober, Kord M.
    Chesney, Margaret
    Mazor, Melissa
    Mausisa, Grace
    Schumacher, Mark
    Conley, Yvette P.
    Sabes, Jennifer Henderson
    Cheung, Steven
    Wallhagen, Margaret
    Levine, Jon D.
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2018, 56 (01) : 88 - 97
  • [8] The Influence of Chemotherapy-Induced Peripheral Neuropathy on Quality of Life of Gynecologic Cancer Survivors
    Matsuoka, Hirofumi
    Nakamura, Keiichiro
    Matsubara, Yuko
    Ida, Naoyuki
    Saijo, Masayuki
    Ogawa, Chikako
    Masuyama, Hisashi
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (07) : 1394 - 1402
  • [9] A longitudinal examination of associations between age and chemotherapy-induced peripheral neuropathy in patients with gynecologic cancer
    Bulls, Hailey W.
    Hoogland, Aasha I.
    Kennedy, Brittany
    James, Brian W.
    Arboleda, Bianca L.
    Apte, Sachin
    Chon, Hye Sook
    Small, Brent J.
    Gonzalez, Brian D.
    Jim, Heather S. L.
    GYNECOLOGIC ONCOLOGY, 2019, 152 (02) : 310 - 315
  • [10] Chemotherapy-induced peripheral neuropathy in African American cancer survivors: Risk factors and quality of life outcomes
    Trendowski, Matthew R.
    Lusk, Christine M.
    Ruterbusch, Julie J.
    Seaton, Randell
    Simon, Michael S.
    Greenwald, Mark K.
    Harper, Felicity W. K.
    Beebe-Dimmer, Jennifer L.
    Schwartz, Ann G.
    CANCER MEDICINE, 2021, 10 (22): : 8151 - 8161